NDAOTICSOLUTION/DROPS
Approved
Jun 1961
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
VOSOL HC (hydrocortisone and acetic acid otic) by Saptalis Pharms is corticosteroid hormone receptor agonists [moa]. First approved in 1961.
Drug data last refreshed 2h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
VOSOL HC is a combination otic solution containing hydrocortisone (a corticosteroid) and acetic acid approved in 1961 for topical treatment of ear infections and inflammation. It works as a corticosteroid hormone receptor agonist to reduce inflammation and suppress immune response in the external ear canal. The acetic acid component provides antimicrobial and anti-inflammatory effects.
LOE Approaching
As a long-established legacy product approaching loss of exclusivity with moderate competitive pressure (30%), teams are likely focused on maximizing remaining years through efficient operations and cost management rather than expansion.
Mechanism of Action
Corticosteroid Hormone Receptor Agonists
Pharmacologic Class:
Corticosteroid
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on VOSOL HC offers limited career growth given its LOE-approaching status and zero linked job openings, but provides valuable experience in legacy product management, regulatory compliance, and lifecycle optimization. This role is best suited for professionals seeking stability and deep operational expertise rather than rapid advancement or launch experience.
Brand Manager
Worked on VOSOL HC at Saptalis Pharms? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.